1 year return (CAGR)
35.37%
Fleury S.A. Exchange (SA, BRL)
FLRY3.SA
21.28
-0.12 (-0.56%)
HealthcareDiagnostics & Research
Loading...
3 year return (CAGR)
12.97%
5 year return (CAGR)
-1.14%
10 year return (CAGR)
3.98%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
11.57B
Price/Sales
1.32
Ent value
19.59B
Price/Book
2.10
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
51.61%
Trailing P/E
16.43
PEG
-
Forward P/E
14.07
EPS growth
7.83%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 21.41 |
| Daily high | 21.52 |
| Daily low | 21.19 |
| Daily Volume | 3.33M |
| All-time high | 31.90 |
| 1y analyst estimate | 17.84 |
| Beta | 0.21 |
| EPS (TTM) | 1.30 |
| Dividend per share | 0.00 |
| Ex-div date | 11 Aug 2026 |
| Next earnings date | 5 Mar 2026 |
Downside potential
Loading...
Downside potential data
| FLRY3.SA | S&P500 | |
| Current price drop from All-time high | -33.30% | -2.63% |
| Highest price drop | -66.43% | -56.47% |
| Date of highest drop | 11 Mar 2025 | 9 Mar 2009 |
| Avg drop from high | -30.15% | -10.68% |
| Avg time to new high | 51 days | 12 days |
| Max time to new high | 1650 days | 1805 days |
News
Fleury SA reports robust financial performance with a 10.1% revenue increase, while navigating industry competition and operational challenges.
May 10, 2026
Investing.com -- TeraWulf Inc. is preparing to raise approximately $3.5 billion in debt to construct a data center campus in Kentucky, marking the company's first entry into the leveraged loan market,...
July 9, 2026
Fleury SA reports an 11.5% revenue increase, driven by strategic acquisitions and robust B2C growth, despite challenges in the B2B segment.
November 8, 2025